Clinical trial
A Cross-sectional Study of COPD and Symptom Variability in MEA Countries
NCT03425760 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cross-sectional Study of COPD and Symptom Variability in MEA Countries
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 7, 2015
- Completion date
- March 31, 2017
- Enrollment
- 3,254 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease